These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17584598)

  • 1. Soluble CD30 in patients with antibody-mediated rejection of the kidney allograft.
    Slavcev A; Honsova E; Lodererova A; Pavlova Y; Sajdlova H; Vitko S; Skibova J; Striz I; Viklicky O
    Transpl Immunol; 2007 Jul; 18(1):22-7. PubMed ID: 17584598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
    Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vitko S; Skibová J; Striz I
    Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
    Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft.
    Pavlova Y; Viklicky O; Slatinska J; Bürgelova M; Süsal C; Skibova J; Honsová E; Striz I; Kolesar L; Slavcev A
    Transpl Immunol; 2011 Jul; 25(1):72-6. PubMed ID: 21376809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of C4d staining as a humoral injury marker.
    Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
    Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of acute renal allograft rejection in early post-transplantation period by soluble CD30.
    Dong W; Shunliang Y; Weizhen W; Qinghua W; Zhangxin Z; Jianming T; He W
    Transpl Immunol; 2006 Jun; 16(1):41-5. PubMed ID: 16701175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
    Choi J; Cho YM; Yang WS; Park TJ; Chang JW; Park SK
    Clin Transplant; 2007; 21(2):159-65. PubMed ID: 17425739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of C4d in renal allograft biopsies in different clinical settings: absence of C4d in grafts from non-heart-beating donors.
    Crespo M; Sole M; Arostegui JL; Mila J; Martorell J; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3688-9. PubMed ID: 16386506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance and implications of capillaritis during acute rejection of kidney allografts.
    Cosio FG; Lager DJ; Lorenz EC; Amer H; Gloor JM; Stegall MD
    Transplantation; 2010 May; 89(9):1088-94. PubMed ID: 20216485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplant soluble CD30 is a better predictor of posttransplant development of donor-specific antibodies and acute vascular rejection than panel reactive antibodies.
    Vaidya S; Partlow D; Barnes T; Gugliuzza K
    Transplantation; 2006 Dec; 82(12):1606-9. PubMed ID: 17198244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C4d-positive renal allograft rejection biopsies in cyclosporine-treated patients: single-center incidence and outcome.
    Valente M; Furian L; Marchini F; Marino S; Cardillo M; Rigotti P; Aiello FB
    Transplant Proc; 2010; 42(6):2214-7. PubMed ID: 20692447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C4d deposits in acute "cell-mediated" rejection: a marker for renal prognosis?
    Neves M; Cotovio P; Machado S; Santos L; Macário F; Alves R; Pratas J; Xavier da Cunha M; Mota A; Campos M
    Transplant Proc; 2012 Oct; 44(8):2360-5. PubMed ID: 23026593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High pretransplantation soluble CD30 levels: impact in renal transplantation.
    Giannoli C; Bonnet MC; Perrat G; Houillon A; Reydet S; Pouteil-Noble C; Villar E; Lefrançois N; Morelon E; Dubois V
    Transplant Proc; 2007 Oct; 39(8):2574-5. PubMed ID: 17954178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
    Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
    Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
    Bartel G; Wahrmann M; Schwaiger E; Kikić Ž; Winzer C; Hörl WH; Mühlbacher F; Hoke M; Zlabinger GJ; Regele H; Böhmig GA
    Transpl Int; 2013 Feb; 26(2):121-30. PubMed ID: 23145861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis.
    Chen Y; Tai Q; Hong S; Kong Y; Shang Y; Liang W; Guo Z; He X
    Transplantation; 2012 Nov; 94(9):911-8. PubMed ID: 23052636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries.
    Aita K; Yamaguchi Y; Shimizu T; Horita S; Furusawa M; Tanabe K; Fuchinoue S; Toma H
    Clin Transplant; 2004; 18 Suppl 11():7-12. PubMed ID: 15191366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.